Global Health Investment Corporation

News

GHIC is pleased to share our latest announcements, partnerships, investments, and new funds.

Jun 11 2025

GHIC Selected to 2025 ImpactAssets 50 Fund Managers

Jun 4 2025

GHIC Co-Leads Antheia’s $56M Series C Financing to Strengthen Resilience in Critical Drug Supply Chains

Jan 28 2025

Medicines Development for Global Health (MDGH) announces Ghana Health Service rollout of moxidectin, a new treatment for river blindness

Jan 16 2025

Micron Biomedical Extends Series A Financing to 33+ Million to Accelerate Commercialization of Needle-Free Therapeutics and Vaccines

Oct 28 2024

GHIC Launches the Frontier Fund to Seed New Innovations to develop novel medical countermeasures

Oct 10 2024

GHIC Invests in Cytovale’s $100 Million Series D to Accelerate Commercial Expansion of its Rapid Sepsis Solution

Oct 9 2024

GHIC invests in AfricInvest's Transform Health Fund through the newly launched Catalytic Health Investment Platform

Oct 3 2024

GHIC and KfW launch Catalytic Health Investment Platform

Nov 15 2023

GHIC Invests in Cytovale’s Series C Financing

Aug 24 2023

GHIC Receives $100 million from BARDA toward Project NextGen goals

Aug 11 2023

GHIC - BARDA Ventures Year 2 Partnership Report

Apr 19 2023

CEPI and GHIC Collaborate to Advance Vaccine R&D for Emerging Infectious Diseases

Nov 28 2022

GHIC Adds Micron Biomedical to Global Health Security Portfolio

Nov 16 2022

GHIC Co-Leads Centivax Seed Round

Nov 2 2022

GHIC Invests in Vaxess Technologies' Series B Financing

Oct 19 2022

GHIC Adds Univercells to Global Health Security Portfolio

Aug 25 2022

GHIC Receives Additional $53M from BARDA

Aug 15 2022

GHIC Invests in Monod Bio's Seed Financing

Jun 2 2022

GHIC Adds Endpoint Health to Global Health Security Portfolio

Mar 10 2022

GHIC Receives Additional BARDA Funding